DrugPatentWatch Database Preview
Alcon Company Profile
What is the competitive landscape for ALCON, and when can generic versions of ALCON drugs launch?
ALCON has fifty-one approved drugs.
There is one US patent protecting ALCON drugs. There is one tentative approval on ALCON drugs.
There are eighteen patent family members on ALCON drugs in sixteen countries and thirty-two supplementary protection certificates in eleven countries.
Summary for Alcon
International Patents: | 18 |
US Patents: | 1 |
Tradenames: | 45 |
Ingredients: | 38 |
NDAs: | 51 |
Patent Litigation for Alcon: | See patent lawsuits for Alcon |
PTAB Cases with Alcon as patent owner: | See PTAB cases with Alcon as patent owner |
Drugs and US Patents for Alcon
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon Labs Inc | ALCAINE | proparacaine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 080027-001 | Approved Prior to Jan 1, 1982 | AT | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
Alcon | CETAPRED | prednisolone acetate; sulfacetamide sodium | OINTMENT;OPHTHALMIC | 087771-001 | Aug 6, 1993 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
Alcon Pharms Ltd | PREDNISOLONE SODIUM PHOSPHATE | prednisolone sodium phosphate | SOLUTION/DROPS;OPHTHALMIC | 081044-001 | Oct 24, 1991 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Alcon
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Alcon Pharms Ltd | NAVSTEL | calcium chloride; dextrose; magnesium chloride; oxiglutatione; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate | SOLUTION;IRRIGATION | 022193-001 | Jul 24, 2008 | 5,578,578 | ➤ Sign Up |
Alcon | PROFENAL | suprofen | SOLUTION/DROPS;OPHTHALMIC | 019387-001 | Dec 23, 1988 | 4,035,376 | ➤ Sign Up |
Alcon | BSS PLUS | calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate | SOLUTION;IRRIGATION | 018469-001 | Approved Prior to Jan 1, 1982 | 4,550,022 | ➤ Sign Up |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for ALCON drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Ophthalmic Solution | 0.03% | ➤ Subscribe | 2004-12-23 |
➤ Subscribe | Ophthalmic Solution | 0.00% | ➤ Subscribe | 2008-11-28 |
International Patents for Alcon Drugs
Country | Document Number | Estimated Expiration |
---|---|---|
Canada | 2431368 | ➤ Sign Up |
World Intellectual Property Organization (WIPO) | 0249614 | ➤ Sign Up |
South Korea | 100767159 | ➤ Sign Up |
Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Alcon Drugs
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|
2014000088 | Germany | ➤ Sign Up | PRODUCT NAME: EZETIMIB ODER PHARMAZEUTISCH ANNEHMBARE SALZE DAVON IN KOMBINATION MIT ATORVASTATIN ODER PHARMAZEUTISCH ANNEHMBARE SALZE DAVON, INSBESONDERE ATORVASTATIN ALS ATORVASTATINCALCIUMTRIHYDRAT; NAT. REGISTRATION NO/DATE: 90223.00.00 20141113; FIRST REGISTRATION: FRANKREICH CIS: 6 928 917 6 20140912 |
2012017 | Lithuania | ➤ Sign Up | PRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127 |
C/GB12/047 | United Kingdom | ➤ Sign Up | PRODUCT NAME: DEXAMETHASONE; REGISTERED: UK EU/1/10/638/001 20100727 |
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.